Fiduciary Trust CO Regeneron Pharmaceuticals, Inc. Transaction History

Fiduciary Trust CO

  • $6.5 Billion
  • Q2 2024

A detailed history of Fiduciary Trust CO transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Fiduciary Trust CO holds 8,496 shares of REGN stock, worth $8.93 Million. This represents 0.14% of its overall portfolio holdings.

Number of Shares
8,496
Previous 8,438 0.69%
Holding current value
$8.93 Million
Previous $8.12 Million 9.95%
% of portfolio
0.14%
Previous 0.13%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
BUY
$883.2 - $1071.19 $51,225 - $62,129
58 Added 0.69%
8,496 $8.93 Million
Q4 2023

Feb 12, 2024
BUY
$775.18 - $881.7 $775 - $881
1 Added 0.01%
8,438 $7.41 Million
Q3 2023

Nov 14, 2023
SELL
$692.45 - $844.37 $29,775 - $36,307
-43 Reduced 0.51%
8,437 $6.94 Million
Q2 2023

Aug 01, 2023
SELL
$700.03 - $830.35 $20,300 - $24,080
-29 Reduced 0.34%
8,480 $6.09 Million
Q1 2023

May 15, 2023
SELL
$680.49 - $826.97 $103,434 - $125,699
-152 Reduced 1.75%
8,509 $6.99 Million
Q4 2022

Feb 13, 2023
SELL
$705.89 - $766.39 $261,179 - $283,564
-370 Reduced 4.1%
8,661 $6.25 Million
Q3 2022

Nov 14, 2022
SELL
$573.97 - $724.32 $3.94 Million - $4.97 Million
-6,859 Reduced 43.17%
9,031 $6.22 Million
Q2 2022

Aug 12, 2022
BUY
$548.35 - $738.84 $2,741 - $3,694
5 Added 0.03%
15,890 $9.39 Million
Q1 2022

May 12, 2022
SELL
$595.12 - $698.43 $74,985 - $88,002
-126 Reduced 0.79%
15,885 $11.1 Million
Q4 2021

Feb 14, 2022
SELL
$543.48 - $670.97 $8,152 - $10,064
-15 Reduced 0.09%
16,011 $10.1 Million
Q3 2021

Nov 12, 2021
BUY
$574.03 - $680.96 $210,669 - $249,912
367 Added 2.34%
16,026 $9.7 Million
Q2 2021

Aug 16, 2021
BUY
$472.8 - $558.54 $140,421 - $165,886
297 Added 1.93%
15,659 $8.75 Million
Q1 2021

May 19, 2021
BUY
$446.73 - $548.2 $35,291 - $43,307
79 Added 0.52%
15,362 $7.27 Million
Q4 2020

Jan 26, 2021
BUY
$478.3 - $607.98 $917,379 - $1.17 Million
1,918 Added 14.35%
15,283 $7.38 Million
Q3 2020

Nov 13, 2020
SELL
$544.75 - $658.21 $521,870 - $630,565
-958 Reduced 6.69%
13,365 $7.48 Million
Q2 2020

Aug 13, 2020
BUY
$493.32 - $643.92 $259,979 - $339,345
527 Added 3.82%
14,323 $8.93 Million
Q1 2020

May 15, 2020
BUY
$336.18 - $494.43 $3,025 - $4,449
9 Added 0.07%
13,796 $6.74 Million
Q4 2019

Feb 04, 2020
BUY
$274.13 - $376.51 $1.29 Million - $1.78 Million
4,721 Added 52.07%
13,787 $5.18 Million
Q3 2019

Nov 12, 2019
BUY
$273.46 - $318.39 $536,528 - $624,681
1,962 Added 27.62%
9,066 $2.52 Million
Q2 2019

Aug 14, 2019
BUY
$299.6 - $414.82 $489,846 - $678,230
1,635 Added 29.9%
7,104 $2.22 Million
Q1 2019

May 07, 2019
BUY
$372.08 - $439.57 $2.03 Million - $2.4 Million
5,469 New
5,469 $2.25 Million

Others Institutions Holding REGN

# of Institutions
1,463
Shares Held
84.5M
Call Options Held
907K
Put Options Held
1.3M
View Full List

About REGENERON PHARMACEUTICALS, INC.

REGN Quotes by TradingView
  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $113B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Fiduciary Trust CO Portfolio

Follow Fiduciary Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fiduciary Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Fiduciary Trust CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email